RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Sihuan Pharmaceutical Holdings Group Stock

Sihuan Pharmaceutical Holdings Group Net Income 2024

Sihuan Pharmaceutical Holdings Group Net Income

23.49 M CNY

Ticker

460.HK

ISIN

BMG8162K1137

WKN

A1C72G

In 2024, Sihuan Pharmaceutical Holdings Group's profit amounted to 23.49 M CNY, a -143.48% increase from the -54.02 M CNY profit recorded in the previous year.

The Sihuan Pharmaceutical Holdings Group Net Income history

YEARNET INCOME (undefined CNY)
2026e2.42
2025e0.1
2024e0.02
2023-0.05
2022-1.91
20210.42
20200.47
2019-2.75
20181.62
20171.45
20161.71
20152.06
20141.67
20131.28
20120.9
20110.82
20100.52
20090.33
20080.24
20070.18
20060.09
20050.04
20040.02

Sihuan Pharmaceutical Holdings Group Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Sihuan Pharmaceutical Holdings Group, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Sihuan Pharmaceutical Holdings Group from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Sihuan Pharmaceutical Holdings Group’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Sihuan Pharmaceutical Holdings Group. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Sihuan Pharmaceutical Holdings Group’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Sihuan Pharmaceutical Holdings Group’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Sihuan Pharmaceutical Holdings Group’s growth potential.

Sihuan Pharmaceutical Holdings Group Revenue, EBIT and net profit per share

DateSihuan Pharmaceutical Holdings Group RevenueSihuan Pharmaceutical Holdings Group EBITSihuan Pharmaceutical Holdings Group Net Income
2026e12.85 B undefined9.51 B undefined2.42 B undefined
2025e2.54 B undefined-574.7 M undefined103.35 M undefined
2024e2.17 B undefined-766.2 M undefined23.49 M undefined
20231.86 B undefined-140.54 M undefined-54.02 M undefined
20222.18 B undefined-536.03 M undefined-1.91 B undefined
20213.04 B undefined676.2 M undefined416.51 M undefined
20202.46 B undefined485.82 M undefined473.38 M undefined
20192.88 B undefined1.39 B undefined-2.75 B undefined
20182.92 B undefined1.72 B undefined1.62 B undefined
20172.75 B undefined1.47 B undefined1.45 B undefined
20163.19 B undefined1.94 B undefined1.71 B undefined
20153.17 B undefined2.07 B undefined2.06 B undefined
20143.08 B undefined1.98 B undefined1.67 B undefined
20132.59 B undefined1.5 B undefined1.28 B undefined
20123.04 B undefined1.02 B undefined904.4 M undefined
20112.24 B undefined997.9 M undefined824 M undefined
20101.04 B undefined615.8 M undefined522.1 M undefined
2009708.9 M undefined415.3 M undefined326.3 M undefined
2008510 M undefined300.5 M undefined237.1 M undefined
2007286.3 M undefined174.6 M undefined179.3 M undefined
2006161.8 M undefined108.9 M undefined90.5 M undefined
2005101.6 M undefined45.8 M undefined38.2 M undefined
200462 M undefined26 M undefined22.2 M undefined

Sihuan Pharmaceutical Holdings Group stock margins

The Sihuan Pharmaceutical Holdings Group margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Sihuan Pharmaceutical Holdings Group. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Sihuan Pharmaceutical Holdings Group.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Sihuan Pharmaceutical Holdings Group's sales revenue. A higher gross margin percentage indicates that the Sihuan Pharmaceutical Holdings Group retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Sihuan Pharmaceutical Holdings Group's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Sihuan Pharmaceutical Holdings Group's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Sihuan Pharmaceutical Holdings Group's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Sihuan Pharmaceutical Holdings Group. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Sihuan Pharmaceutical Holdings Group's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Sihuan Pharmaceutical Holdings Group Margin History

Sihuan Pharmaceutical Holdings Group Gross marginSihuan Pharmaceutical Holdings Group Profit marginSihuan Pharmaceutical Holdings Group EBIT marginSihuan Pharmaceutical Holdings Group Profit margin
2026e69.64 %73.97 %18.8 %
2025e69.64 %-22.63 %4.07 %
2024e69.64 %-35.28 %1.08 %
202369.64 %-7.55 %-2.9 %
202268.2 %-24.58 %-87.79 %
202179.99 %22.26 %13.71 %
202077.69 %19.71 %19.21 %
201979.54 %48.45 %-95.66 %
201881.55 %59.08 %55.53 %
201772.36 %53.35 %52.77 %
201668.71 %60.75 %53.62 %
201570.35 %65.51 %65.12 %
201468.46 %64.17 %54.19 %
201356.28 %57.88 %49.68 %
201275.25 %33.62 %29.73 %
201176.47 %44.51 %36.75 %
201071.82 %59.39 %50.35 %
200972.93 %58.58 %46.03 %
200873.82 %58.92 %46.49 %
200778.87 %60.98 %62.63 %
200677.19 %67.31 %55.93 %
200554.33 %45.08 %37.6 %
200457.1 %41.94 %35.81 %

Sihuan Pharmaceutical Holdings Group Aktienanalyse

What does Sihuan Pharmaceutical Holdings Group do?

Sihuan Pharmaceutical Holdings Group Ltd is a leading company in the Chinese pharmaceutical industry that focuses on research, development, production, and marketing of drugs, especially for the treatment of cardiovascular diseases and central nervous system diseases. The company was founded in 2001 and has become one of the largest and most successful companies in the Chinese pharmaceutical industry. It is listed on the stock exchange and has its headquarters in Beijing, China. Sihuan Pharmaceutical's business model is based on a combined strategy of researching and developing new drugs tailored to the Chinese market, as well as licensing and distributing existing drugs from both domestic and international sources. The company is divided into various business divisions to maximize its core competencies and maintain growth. The cardiovascular division is one of the most important divisions, producing and distributing cardiovascular drugs used to treat conditions such as hypertension, heart failure, arrhythmias, and other cardiovascular diseases. The central nervous system division is another important division, producing and distributing drugs to treat neurological disorders such as depression, schizophrenia, and epilepsy. In addition, the company also has products in the areas of antibiotics, antivirals, and gastroenterology. Sihuan Pharmaceutical's research and development department focuses on the discovery and development of new active substances, as well as improving existing drugs. The company collaborates with leading universities and research institutions in China and globally to develop innovative approaches in pharmacy. Sihuan Pharmaceutical has also established a strong presence in the Chinese market, building an extensive distribution network throughout China and working closely with other key players in the industry to strengthen its market position. In summary, Sihuan Pharmaceutical Holdings Group Ltd is a significant player in the Chinese pharmaceutical industry, specializing in the research, development, production, and marketing of drugs for the treatment of cardiovascular diseases and central nervous system diseases. The company is divided into multiple business divisions and has a strong presence in the Chinese market. With its strong research and development department, Sihuan Pharmaceutical is committed to improving the health and well-being of millions of people worldwide. Sihuan Pharmaceutical Holdings Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Sihuan Pharmaceutical Holdings Group's Profit Margins

The profit margins of Sihuan Pharmaceutical Holdings Group represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Sihuan Pharmaceutical Holdings Group's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Sihuan Pharmaceutical Holdings Group's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Sihuan Pharmaceutical Holdings Group's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Sihuan Pharmaceutical Holdings Group’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Sihuan Pharmaceutical Holdings Group stock

How much profit has Sihuan Pharmaceutical Holdings Group made this year?

Sihuan Pharmaceutical Holdings Group has made 23.49 M CNY this year.

How has the profit developed compared to last year?

The profit has increased by -143.48% compared to last year fallen

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Sihuan Pharmaceutical Holdings Group publish its earnings?

Sihuan Pharmaceutical Holdings Group publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Sihuan Pharmaceutical Holdings Group?

The profits of Sihuan Pharmaceutical Holdings Group are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Sihuan Pharmaceutical Holdings Group?

You can learn more about the earnings of Sihuan Pharmaceutical Holdings Group by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Sihuan Pharmaceutical Holdings Group pay?

Over the past 12 months, Sihuan Pharmaceutical Holdings Group paid a dividend of 0.07 CNY . This corresponds to a dividend yield of about 14.78 %. For the coming 12 months, Sihuan Pharmaceutical Holdings Group is expected to pay a dividend of 0.07 CNY.

What is the dividend yield of Sihuan Pharmaceutical Holdings Group?

The current dividend yield of Sihuan Pharmaceutical Holdings Group is 14.78 %.

When does Sihuan Pharmaceutical Holdings Group pay dividends?

Sihuan Pharmaceutical Holdings Group pays a quarterly dividend. This is distributed in the months of June, October, July, October.

How secure is the dividend of Sihuan Pharmaceutical Holdings Group?

Sihuan Pharmaceutical Holdings Group paid dividends every year for the past 16 years.

What is the dividend of Sihuan Pharmaceutical Holdings Group?

For the upcoming 12 months, dividends amounting to 0.07 CNY are expected. This corresponds to a dividend yield of 14.49 %.

In which sector is Sihuan Pharmaceutical Holdings Group located?

Sihuan Pharmaceutical Holdings Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von Sihuan Pharmaceutical Holdings Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Sihuan Pharmaceutical Holdings Group from 10/10/2024 amounting to 0.021 CNY, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.

When did Sihuan Pharmaceutical Holdings Group pay the last dividend?

The last dividend was paid out on 10/10/2024.

What was the dividend of Sihuan Pharmaceutical Holdings Group in the year 2023?

In the year 2023, Sihuan Pharmaceutical Holdings Group distributed 0.118 CNY as dividends.

In which currency does Sihuan Pharmaceutical Holdings Group pay out the dividend?

The dividends of Sihuan Pharmaceutical Holdings Group are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Sihuan Pharmaceutical Holdings Group

Our stock analysis for Sihuan Pharmaceutical Holdings Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sihuan Pharmaceutical Holdings Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.